Guo L - Search Results

1

Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer.

Wu SG, He ZY, Zhou J, Sun JY, Li FY, Lin Q, Guo L, Lin HX. Wu SG, et al. Among authors: guo l. Breast. 2014 Feb;23(1):88-93. doi: 10.1016/j.breast.2013.11.003. Epub 2013 Dec 2. Breast. 2014. PMID: 24291374

2

[Phase I study of capecitabine with concurrent radiotherapy in early-stage nasopharyngeal carcinoma].

Guo L, Lin HX, Li FY, Li Q, Qiu F, Luo DH, Guo X, Hong MH. Guo L, et al. Among authors: guo x. Zhonghua Zhong Liu Za Zhi. 2004 Apr;26(4):250-3. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15312392 Clinical Trial. Chinese.

3

Phase I study of TPF neoadjuvant chemotherapy followed by radical radiotherapy in advanced nasopharyngeal carcinoma.

Guo L, Lin HX, Xu M, Chen QY, Wang CT, Huang PY. Guo L, et al. Chin J Cancer. 2010 Feb;29(2):136-9. doi: 10.5732/cjc.009.10367. Chin J Cancer. 2010. PMID: 20109339 Free article. Clinical Trial.

4

Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma.

Ge N, Lin HX, Xiao XS, Guo L, Xu HM, Wang X, Jin T, Cai XY, Liang Y, Hu WH, Kang T. Ge N, et al. Among authors: guo l. J Transl Med. 2010 Oct 12;8:94. doi: 10.1186/1479-5876-8-94. J Transl Med. 2010. PMID: 20937145 Free PMC article.

5

Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.

Lv X, Xiang YQ, Cao SM, Qian CN, Li NW, Guo L, Mai HQ, Chen QY, Huang PY, Luo D, Cao KJ, Hong MH, Guo X. Lv X, et al. Among authors: guo x, guo l. Head Neck. 2011 Jun;33(6):780-5. doi: 10.1002/hed.21541. Epub 2010 Oct 21. Head Neck. 2011. PMID: 20967862

6

Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma.

Lin HX, Hua YJ, Chen QY, Luo DH, Sun R, Qiu F, Mo HY, Mai HQ, Guo X, Xian LJ, Hong MH, Guo L. Lin HX, et al. Among authors: guo x, guo l. Chin J Cancer. 2013 Sep;32(9):502-11. doi: 10.5732/cjc.013.10004. Epub 2013 Jul 2. Chin J Cancer. 2013. PMID: 23816561 Free PMC article. Clinical Trial.

7

Flotillin-2 is associated with breast cancer progression and poor survival outcomes.

Wang X, Yang Q, Guo L, Li XH, Zhao XH, Song LB, Lin HX. Wang X, et al. Among authors: guo l. J Transl Med. 2013 Aug 15;11:190. doi: 10.1186/1479-5876-11-190. J Transl Med. 2013. PMID: 23945257 Free PMC article.

8

Benefit of post-mastectomy radiotherapy of the supra-/infraclavicular lymphatic drainage area in breast cancer patients.

He ZY, Wu SG, Zhou J, Sun JY, Li FY, Lin Q, Guo L, Lin HX. He ZY, et al. Among authors: guo l. Asian Pac J Cancer Prev. 2014;15(14):5557-63. doi: 10.7314/apjcp.2014.15.14.5557. Asian Pac J Cancer Prev. 2014. PMID: 25081664 Free article.

9

The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients.

Jiang R, Zou X, Hu W, Fan YY, Yan Y, Zhang MX, You R, Sun R, Luo DH, Chen QY, Huang PY, Hua YJ, Guo L, Chen MY. Jiang R, et al. Among authors: guo l. Tumour Biol. 2015 Sep;36(10):7775-87. doi: 10.1007/s13277-015-3505-0. Epub 2015 May 6. Tumour Biol. 2015. PMID: 25944165

10

Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.

Yang Q, Lin H, Wu S, Lei F, Zhu X, Song L, Hong M, Guo L. Yang Q, et al. Among authors: guo l. PLoS One. 2015 Aug 25;10(8):e0136448. doi: 10.1371/journal.pone.0136448. eCollection 2015. PLoS One. 2015. PMID: 26305455 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,207 results

Search Page